###begin article-title 0
Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
###xml 575 583 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">patients</span>
Vitamin D has been shown to exert manifold immunomodulatory effects. Type 1 diabetes mellitus (T1DM) is regarded to be immune-mediated and vitamin D prevents the development of diabetes in the NOD mouse. We studied the association between T1DM and the initiation codon polymorphism in exon 2 of the vitamin D receptor gene in a Japanese population. We also investigated associations between the vitamin D receptor polymorphism and GAD65-antibody (Ab) positivity. We carried out polymerase chain reaction-restriction fragment length polymorphism analysis in 110 Japanese T1DM patients and 250 control subjects. GAD65 antibodies were assessed in 78 patients with T1DM.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
We found a significantly higher prevalence of the F allele / the FF genotype in the patients compared to the controls (P = 0.0069 and P = 0.014, respectively). Genotype and allele frequencies differed significantly between GAD65-Ab-positive patients and controls (P = 0.017 and P = 0.012, respectively), but neither between GAD65-Ab-negative patients and controls (P = 0.68 and P = 0.66, respectively) nor between GAD65-Ab-positive and -negative patients (P = 0.19 and P = 0.16, respectively).
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
Our findings suggest that the vitamin D receptor initiation codon polymorphism influences genetic susceptibility to T1DM among the Japanese. This polymorphism is also associated with GAD65-Ab-positive T1DM, although the absence of a significant difference between GAD65-Ab-negative patients and controls might be simply due to the small sample size of patients tested for GAD65 antibodies.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 420 425 <span type="species:ncbi:9606">human</span>
Type 1 diabetes mellitus (T1DM) is a multifactorial disease with a strong genetic component [1]. The main genetic contribution to T1DM susceptibility lies in the major histocompatibility complex (MHC) on the short arm of chromosome 6; several non-MHC chromosomal regions are also involved [2]. Several approaches have been used to identify T1DM susceptibility regions, including case-control studies of candidate genes [human leukocyte antigen (HLA), insulin gene regulatory region, interleukin-1 receptor type 1 (ILIR1)] [3,4,5,6], combined linkage and association-based studies of candidate genes [cytotoxic T lymphocyte associated-4 (CTLA-4)] [7], and systematic total genome searches in addition to analyses of individual chromosomal regions [8,9,10,11,12,13,14,15,16].
###end p 8
###begin p 9
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 272 280 <span type="species:ncbi:9606">children</span>
###xml 305 313 <span type="species:ncbi:9606">children</span>
There are clear differences in immunogenetic predisposition to T1DM between countries, and disease incidence seems to vary along with these differences in predisposition [1]. The incidence of T1DM in Southern India (10.4/100000 cases per year) is similar to that in Asian children in the UK and Caucasian children of European extraction [17,18]. While an MHC component is apparent [19,20] in T1DM susceptibility in Southern India, no association with either the insulin gene [20] or ILIR1 [6] has been found there in case-control studies. This suggests possible differences in the non-MHC T1DM component between Southern Indians and Caucasians of European extraction. In the latter population, an association with the insulin gene has been universally reported [4,5,21], and an IL1R1 association with T1DM has been reported in some Northern Europeans [6,22].
###end p 9
###begin p 10
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tru9</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 830 833 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 836 839 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 940 943 940 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 976 984 <span type="species:ncbi:9606">patients</span>
VDR gene polymorphisms influence susceptibility to osteoporosis [23,24,25], primary hyperparathyroidism [26,27], and autoimmune diseases such as Graves' disease [28,29], Hashimoto's thyroiditis [30], and multiple sclerosis [31]. Allelic variation in VDR also influences susceptibility to T1DM in Indian Asians [17], Germans [32], and Taiwanese [33]. There are six known polymorphisms in the VDR locus: an exon 2 initiation codon polymorphism, which is detected with FokI restriction enzyme [34,35,36,37], the BsmI, Tru9I, and ApaI restriction fragment length polymorphisms (RFLPs) located between exons 8 and 9 [23,38], the TaqI RFLP located in exon 9 [23], and a poly A polymorphism downstream of the 3' untranslated region [39,40]. There is apparently no significant linkage disequilibrium between the FokI polymorphism and the BsmI, ApaI, and TaqI polymorphisms [34,35,36,37]. In this study, we analyzed the exon 2 initiation codon (VDR-FokI) gene polymorphism in Japanese patients with T1DM. We also investigated associations between this VDR polymorphism and GAD65 antibody (Ab) status, an immune marker.
###end p 10
###begin title 11
Subjects and Methods
###end title 11
###begin title 12
Subjects
###end title 12
###begin p 13
###xml 1072 1074 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1075 1077 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1078 1080 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 72 75 <span type="species:ncbi:9606">men</span>
###xml 83 88 <span type="species:ncbi:9606">women</span>
###xml 781 789 <span type="species:ncbi:9606">patients</span>
###xml 846 849 <span type="species:ncbi:9606">men</span>
###xml 858 863 <span type="species:ncbi:9606">women</span>
###xml 1211 1219 <span type="species:ncbi:9606">patients</span>
The study population comprised 110 unrelated Japanese T1DM patients (50 men and 60 women) from the Tokyo metropolitan area. T1DM was diagnosed on the basis of sudden-onset of severe symptoms or rapid progress to overt diabetes and dependence on exogenous insulin due to absolute insulin deficiency, according to the 1997 Committee of the American Diabetes Association (Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997) criteria. All subjects were insulin-dependent at the time of the study, although their beta-cell reserve, estimated by measurement of fasting serum C-peptide, was variable. Slowly progressive T1DM was not included in this study. Mean age at onset of T1DM was 26.0 +/- 3.7 years (mean +/- SEM). GAD65 antibodies were assessed in 78 patients. Two hundred and fifty unrelated Japanese subjects (100 men and 150 women) without clinical evidence or family history of diabetes mellitus or autoimmune disease were selected as controls. The controls used in the present study are identical with the previously published controls [28,29,30]. This study was carried out in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from patients and controls.
###end p 13
###begin title 14
Genotype analysis
###end title 14
###begin p 15
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 549 552 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 681 684 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 819 822 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 860 863 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
Genomic DNA was isolated from whole blood with the Genomix kit (Talent, Trieste, Italy). Primers VDR2a (5'-AGCTGGCCCTGGCACTGACTCTTGCTCT-3') and VDR2b (5'-ATGGAAACACCTTGCTTCTTCTCCCTC-3') and 100 ng of genomic DNA were combined in a polymerase chain reaction (PCR) mixture to amplify a 265-bp fragment containing the polymorphism in the initiation codon of VDR [34]. PCR products were digested with FokI at 37degreesC for 3 h and then subjected to electrophoresis in 2% agarose gel containing ethidium bromide. Cleavage of homozygous DNA carrying the FokI polymorphism (FF) generates 69-bp and 196-bp fragments. Restriction endonuclease cleavage analysis of DNA heterozygous for the FokI polymorphism (Ff) results in uncleaved (265-bp) DNA as well as the 69-bp and 196-bp products. Homozygous DNA that does not carry the FokI polymorphism (ff) is not cleaved by FokI and appears as a single 265-bp fragment on agarose gels.
###end p 15
###begin title 16
Measurement of GAD65 antibody
###end title 16
###begin p 17
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
GAD65 Ab was detected with a radioligand binding assay described previously [41]. Intra- and inter-assay coefficients of variation were less than 5%. At the First International GAD Autoantibody Workshop, our GAD65 Ab assay yielded 100% sensitivity (% positive samples confirmed to be positive) and 100% specificity (% known negative samples confirmed to be negative).
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 73 74 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 184 186 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 189 190 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Genotypes and alleles in patients and controls were compared with the Chi2-tests for 2 x 2 and 2 x 3 tables and by Fisher's exact test. Relative risk was calculated by Woolf's method [42]. P < 0.05 was considered significant. We corrrected for multiple testing using the Bonferoni correction.
###end p 19
###begin title 20
Results
###end title 20
###begin title 21
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Genotype and allele frequencies of the VDR-FokI gene polymorphism in patients and controls
###end title 21
###begin p 22
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 324 329 <span type="species:ncbi:9606">women</span>
PCR-RFLP was used to examine VDR-FokI genotype distributions in T1DM patients and controls (Table 1). The distribution of VDR genotypes was similar between the male and female control subjects (data not shown). The genotype distribution in our control subjects was similar to that in a previously reported group of Japanese women who resided in Kagawa prefecture [25].
###end p 22
###begin p 23
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
VDR-FokI polymorphism in study subjects
###end p 23
###begin p 24
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 73 74 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 144 145 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 176 177 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 187 188 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 191 192 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 262 263 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 293 294 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 305 306 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
Values shown are the number of subjects (percentage in parentheses). aChi2 test of heterogeneity between T1DM patients and control subjects. Chi2 = 8.48, 2 degrees of freedom; P = 0.014. bChi2 test of heterogeneity between T1DM patients and control subjects. Chi2 = 7.29, 1 degree of freedom; P = 0.0069. cRelative risk ratio for F phenotype = 2.4.
###end p 24
###begin p 25
###xml 103 104 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 135 136 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 321 322 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 352 353 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
The distribution of genotype frequencies differed significantly between T1DM patients and controls (Chi2 = 8.48, 2 degrees of freedom, P = 0.014), with the VDR FF genotype occurring more frequently in the T1DM patients. The distribution of allele frequencies differed significantly between T1DM patients and controls (Chi2 = 7.29, 1 degree of freedom, P = 0.0069). The relative risk conferred by at least one F allele (FF or Ff) was 2.4.
###end p 25
###begin p 26
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
Genotype distributions among patients and controls did not differ according to age, height, or weight (data not shown). No significant linkage disequilibrium was detected between this polymorphism and the BsmI polymorphism in intron 8 and exon 9 in the T1DM patients (data not shown).
###end p 26
###begin title 27
VDR-FokI gene polymorphism in GAD65-antibody-positive and -negative subjects
###end title 27
###begin p 28
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 229 230 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 261 262 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 397 398 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 428 429 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 651 652 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 683 684 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 699 700 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 730 731 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 860 861 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 892 893 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 908 909 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 939 940 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
###xml 818 826 <span type="species:ncbi:9606">patients</span>
We investigated association between VDR-FokI gene polymorphism and GAD65-Ab positivity in 78 patients (Table 2). The distribution of genotype frequencies differed significantly between GAD65-Ab-positive patients and controls (Chi2 = 8.14, 2 degrees of freedom, P = 0.017). The distribution of allele frequencies also differed significantly between GAD65-Ab-positive T1DM patients and controls (Chi2 = 6.32, 1 degree of freedom, P = 0.012). The relative risk conferred by at least one F allele (FF or Ff) was 2.0. The distribution of genotype and allele frequencies did not differ significantly between GAD65-Ab-negative T1DM patients and controls (Chi2 = 0.78, 2 degrees of freedom, P = 0.68 and Chi2 = 0.19, 1 degree of freedom, P = 0.66). The genotype and allele distributions in the GAD65-Ab-positive and -negative patients did not differ significantly (Chi2 = 3.36, 2 degrees of freedom, P = 0.19 and Chi2 = 1.98, 1 degree of freedom, P = 0.16, respectively).
###end p 28
###begin p 29
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
VDR-FokI polymorphism in study subjects analyzed with respect to GAD65 antibody status
###end p 29
###begin p 30
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 80 81 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 166 167 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 198 199 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 209 210 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 213 214 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 299 300 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 330 331 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 341 342 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
Values shown are the number of subjects with the percentage in parentheses. aChi2 test of heterogeneity between GAD65-positive T1DM patients and control subjects. Chi2 = 8.14, 2 degrees of freedom; P = 0.017. bChi2 test of heterogeneity between GAD65-positive T1DM patients and control subjects. Chi2 = 6.32, 1 degree of freedom; P = 0.012. cRelative risk ratio for F phenotype (GAD65-positive T1DM) = 2.0.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 217 219 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 395 397 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 448 450 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 573 574 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 575 576 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 577 579 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 580 582 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 583 585 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 586 588 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 589 591 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 592 594 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 595 597 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 598 600 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 601 603 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
We found an association between the VDR-FokI polymorphism and T1DM in our study population. Selective beta-cell destruction, which is observed in T1DM, is thought to be caused by a T-cell-mediated autoimmune process [43]. Genetic susceptibility to T1DM is well established, and certain HLA pheno- and genotypes are associated with T1DM; for example, HLA-DR 3 and -DR 4 in Caucasian populations [43], and HLA-DR 4 and -DR 9 in Japanese populations [44]. Recent genome-wide searches and several candidate gene studies have revealed new regions possibly associated with T1DM [8,9,10,11,12,13,14,15,16,45,46].
###end p 32
###begin p 33
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 244 246 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 247 249 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 250 252 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 253 255 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 433 435 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 735 737 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 860 862 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 984 986 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 743 749 <span type="species:ncbi:10090">murine</span>
Vitamin D hormone has important immunomodulatory properties and influences insulin secretion [47]. This hormone inhibits T-cell activation both in vitro and in vivo and the secretion of IL-1, IL-2, IL-6, IL-12, TNF, and interferon (IFN)-gamma [48,49,50,51]. These cytokines play important roles in the development of T cells, which are believed to be involved in the pathogenesis of several chronic inflammatory autoimmune diseases [52]. In recent studies, 1,25-dihydroxyvitamin D3 was shown to inhibit IL-12 production by macrophages and dendritic cells by suppressing transcriptional activation of the p35 and p45 genes, which code for subunits of IL-12. Transcriptional repression of the p40 gene is dependent on expression of VDR [53]. In murine models, vitamin D administration prevents development of T1DM as well as the associated autoimmune insulitis [54]. In Bangladeshi subjects, vitamin D levels were found to be reduced in those subjects most at risk for type 2 diabetes [55].
###end p 33
###begin p 34
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
###xml 777 785 <span type="species:ncbi:9606">patients</span>
The VDR locus has been studied extensively for association with susceptibility to osteoporosis [23,24,25], primary hyperparathyroidism [26,27], and autoimmune diseases such as Graves' disease [28,29], Hashimoto's thyroiditis [30], and multiple sclerosis [31]. The BsmI B allele of VDR has been associated with reduced bone mineral density in some studies [23,56], but not in others [57,58], and at least one study showed the b allele of VDR to be associated with particular subtypes of osteoporosis [59]. The bb genotype has been associated with primary hyperparathyroidism in Swedish patients [26,27] and multiple sclerosis in Japanese patients [31]. The FokI FF genotype for VDR has been associated with both Graves' disease [28] and Hashimoto's thyroiditis [30] in Japanese patients.
###end p 34
###begin p 35
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 596 599 596 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 844 847 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 902 905 902 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
###xml 1079 1087 <span type="species:ncbi:9606">patients</span>
The role of the VDR gene in T1DM has also been examined [17,32]. Evidence for preferential transmission of the VDR b allele to affected offspring has been found in Indian Asians [17]. Pani et al. [32] detected significant haplotype-wise extended transmission disequilibrium for the BsmI/ApaI/TaqI, BsmI/TaqI, and ApaI/TaqI haplotypes in Germans; analysis of the FokI site did not provide additional information on susceptibility. Recently, Chang et al. confirmed the association of these markers with T1DM in the Taiwanese population [33]. Allelic frequencies for this and other VDR RFLPs (ApaI, TaqI) differ between Caucasian and Japanese subjects [24,60]. RFLP analysis of VDR revealed that the BBAAtt genotype is relatively common (16.7%) in Caucasian populations and rare in Japanese populations (1.4%) [24]. Therefore, we investigated VDR-FokI polymorphism in this study. Our investigation of VDR-FokI genotype frequencies in Japanese subjects revealed that the FF genotype is significantly more common in T1DM patients (47%) than in control subjects (33%), suggesting that patients with this genotype may be predisposed to T1DM [28].
###end p 35
###begin p 36
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 562 564 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 655 656 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 713 715 713 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 864 867 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
In contrast to our findings for T1DM, an increased frequency of the F allele, because it encodes a VDR isoform with higher transcriptional activity, has a beneficial effects in the prevention of osteoporosis, and should lead to higher immunomodulatory activity of the vitamin D hormone [61]. Recently, Colin et al. [62] demonstrated in peripheral blood mononuclear cells with a natural VDR genotype a direct functional consequence of the VDR-FokI polymorphism for the action of 1,25-dihydroxyvitamin D3. They found that the FF genotype had a significant lower ED50 than the Ff genotype corresponding to an allele dose effect of 0.32 nM per f allele copy (P = 0.0036), while for BsmI genotypes no differences in ED50 were observed [62]. The apparent discrepancy could be due to the effect of the genetic susceptibility to T1DM and ethnic differences related to VDR-FokI allelic prevalences as well as to environmental and geographic variations in calcium intake, exposure to sunshine, or other factors.
###end p 36
###begin p 37
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 551 554 551 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
###xml 761 769 761 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 969 977 <span type="species:ncbi:9606">patients</span>
In the present study, the FF genotype (or presence of the F allele) of the VDR-FokI polymorphism was also associated with GAD65-Ab-positive T1DM in the Japanese population, although the absence of a significant difference between GAD65-Ab-negative patients and controls might be simply due to the small sample size of patients tested for GAD65 antibodies. McDermott et al. [17] found no relation between the VDR-BsmI, -TaqI, or -ApaI polymorphism and GAD65 Ab status in Indian Asians. Thus, since there is apparently no linkage disequilibrium between FokI polymorphism and BsmI, ApaI, and TaqI polymorphisms [34,35,36,37], the VDR-FokI polymorphism seems to contribute to immunological heterogeneity of T1DM, although the mechanism remains unclear. Although no in vitro or animal studies have shown that VDR function is directly associated with antibody production in autoimmune disease or that this polymorphism might alter immune function, GAD65-Ab-negative diabetes patients could be subject to a different disease process or a different path of clinical development with regards to a possible VDR contribution. Both possibilities warrant further study.
###end p 37
###begin title 38
Conclusions
###end title 38
###begin p 39
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tru9</italic>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 478 481 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fok</italic>
In conclusion, our data indicates an association between the VDR gene and T1DM among the Japanese. We suggest that the FF genotype may predispose Japanese individuals to T1DM and that this genotype appears to be a marker for T1DM. The role of the VDR gene polymorphism should be studied further in other populations, and other polymorphisms, such as the BsmI, ApaI, Tru9I and TaqI polymorphisms, should be analyzed for association with T1DM susceptibility. In addition, the VDR-FokI polymorphism showed a possible association with GAD65-Ab-positive T1DM. The VDR plays a role in lymphocyte response to microorganisms (tuberculin reactive status in pulmonary tuberculosis, leprosy etc.). Thus, it is conceivable that it may also be involved in immune response to self antigens e.g. GAD65 antibodies.
###end p 39
###begin title 40
Pre-publication history
###end title 40
###begin p 41
The pre-publication history for this paper can be accessed here:
###end p 41
###begin p 42

###end p 42
###begin title 43
Acknowledgments
###end title 43
###begin p 44
This work was supported, in part, by the High-Technology Research Center Project from the Ministry of Education, Science, Sports and Culture of Japan.
###end p 44
###begin p 45
Competing interests
###end p 45
###begin p 46
Have you in the past five years received reimbursements, fees, funding, or salary from an organisation that may in any way gain or lose financially from the publication of this paper? No.
###end p 46
###begin p 47
Do you hold any stocks or shares in an organisation that may in any way gain or lose financially from the publication of this paper? No.
###end p 47
###begin p 48
Do you have any other financial competing interests? No.
###end p 48
###begin p 49
Are there any non-financial competing interests you would like to declare in relation to this paper? No.
###end p 49
###begin article-title 50
Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus.
###end article-title 50
###begin article-title 51
Multifactorial inheritance in type 1 diabetes.
###end article-title 51
###begin article-title 52
HLA antigens and diabetes mellitus.
###end article-title 52
###begin article-title 53
###xml 30 35 <span type="species:ncbi:9606">human</span>
A polymorphic marker near the human insulin gene is associated with insulin dependent diabetes mellitus.
###end article-title 53
###begin article-title 54
Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11.
###end article-title 54
###begin article-title 55
An association between type 1 diabetes and the interleukin-1 receptor type 1 gene.
###end article-title 55
###begin article-title 56
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes.
###end article-title 56
###begin article-title 57
###xml 25 30 <span type="species:ncbi:9606">human</span>
A genome-wide search for human type 1 diabetes susceptibility genes.
###end article-title 57
###begin article-title 58
A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin dependent diabetes mellitus.
###end article-title 58
###begin article-title 59
###xml 25 30 <span type="species:ncbi:9606">human</span>
A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.
###end article-title 59
###begin article-title 60
Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8.
###end article-title 60
###begin article-title 61
Affected sibpair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27.
###end article-title 61
###begin article-title 62
The HOXD8 locus (2q31) is linked to type 1 diabetes.
###end article-title 62
###begin article-title 63
Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus.
###end article-title 63
###begin article-title 64
Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.
###end article-title 64
###begin article-title 65
Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33.
###end article-title 65
###begin article-title 66
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians.
###end article-title 66
###begin article-title 67
Childhood-onset diabetes in the white and South Asian population in Leicestershire, UK.
###end article-title 67
###begin article-title 68
###xml 56 64 <span type="species:ncbi:9606">patients</span>
HLA-DR and -DQ genotyping in insulin-dependent diabetes patients in South India.
###end article-title 68
###begin article-title 69
The genetic predisposition to fibrocalculous pancreatic diabetes.
###end article-title 69
###begin article-title 70
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility.
###end article-title 70
###begin article-title 71
Chracterization of polymorphisms of an interleukin-1 receptor type 1 gene (IL1R1) promoter region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM).
###end article-title 71
###begin article-title 72
Prediction of bone density from vitamin D receptor alleles.
###end article-title 72
###begin article-title 73
###xml 88 93 <span type="species:ncbi:9606">women</span>
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women.
###end article-title 73
###begin article-title 74
###xml 152 157 <span type="species:ncbi:9606">women</span>
A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women.
###end article-title 74
###begin article-title 75
Vitamin D receptor genotypes in primary hyperparathyroidism.
###end article-title 75
###begin article-title 76
###xml 102 107 <span type="species:ncbi:9606">human</span>
Vitamin D receptor (VDR) and parathyroid hormone mRNA levels correspond to polymorphic VDR alleles in human parathyroid tumors.
###end article-title 76
###begin article-title 77
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
###end article-title 77
###begin article-title 78
Vitamin D Receptor Gene Polymorphism is Associated with Graves' Disease in the Japanese Population.
###end article-title 78
###begin article-title 79
Vitamin D Receptor Gene Polymorphisms in Hashimoto's thyroiditis.
###end article-title 79
###begin article-title 80
Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese.
###end article-title 80
###begin article-title 81
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans.
###end article-title 81
###begin article-title 82
Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.
###end article-title 82
###begin article-title 83
###xml 171 176 <span type="species:ncbi:9606">women</span>
The presence of a polymorphism at the translation initiation site of the vitamin D receptor is associated with low bone mineral density in postmenopausal Mexican-American women.
###end article-title 83
###begin article-title 84
###xml 133 138 <span type="species:ncbi:9606">women</span>
Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: The OFELY study.
###end article-title 84
###begin article-title 85
###xml 122 127 <span type="species:ncbi:9606">women</span>
The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women.
###end article-title 85
###begin article-title 86
Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphism.
###end article-title 86
###begin article-title 87
###xml 52 57 <span type="species:ncbi:9606">human</span>
Identification of a novel Tru9I polymorphism in the human vitamin D receptor gene.
###end article-title 87
###begin article-title 88
Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies.
###end article-title 88
###begin article-title 89
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
###end article-title 89
###begin article-title 90
Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes mellitus in Japanese.
###end article-title 90
###begin article-title 91
On estimating the relation between blood group and disease.
###end article-title 91
###begin article-title 92
Insulin-dependent diabetes mellitus as an autoimmune disease.
###end article-title 92
###begin article-title 93
###xml 86 94 <span type="species:ncbi:9606">patients</span>
HLA DR antigens in adult-onset and juvenile-onset Japanese insulin-dependent diabetic patients.
###end article-title 93
###begin article-title 94
A search for type 1 diabetes susceptibility genes in families from the United Kingdom.
###end article-title 94
###begin article-title 95
###xml 34 39 <span type="species:ncbi:9606">human</span>
A second generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus.
###end article-title 95
###begin article-title 96
Vitamin D deficiency inhibits pancreatic secretion of insulin.
###end article-title 96
###begin article-title 97
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45RO+ cells.
###end article-title 97
###begin article-title 98
1,25-Dihydroxyvitamin D inhibits antigen-induced T cell activation.
###end article-title 98
###begin article-title 99
###xml 96 97 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 40 45 <span type="species:ncbi:9606">human</span>
Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3.
###end article-title 99
###begin article-title 100
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Immunomodulatory actions of 1,25-dihydroxyvitamin D3.
###end article-title 100
###begin article-title 101
The role of IL-12 in the induction of organ-specific autoimmune diseases.
###end article-title 101
###begin article-title 102
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
###end article-title 102
###begin article-title 103
###xml 23 24 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
1,25-dihydroxyvitamin D3 prevents insulitis in NOD mice.
###end article-title 103
###begin article-title 104
Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians.
###end article-title 104
###begin article-title 105
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 133 138 <span type="species:ncbi:9606">women</span>
The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women.
###end article-title 105
###begin article-title 106
###xml 124 129 <span type="species:ncbi:9606">women</span>
The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women.
###end article-title 106
###begin article-title 107
Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.
###end article-title 107
###begin article-title 108
A large scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density.
###end article-title 108
###begin article-title 109
###xml 82 87 <span type="species:ncbi:9606">women</span>
Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women.
###end article-title 109
###begin article-title 110
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.
###end article-title 110
###begin article-title 111
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 88 93 <span type="species:ncbi:9606">human</span>
Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3.
###end article-title 111

